← Company intelligence

Robot maker · registered

Moon Surgical

Corporate marketmedicalCurated record

Maestro robotic surgical assistance platform runs NVIDIA Holoscan edge compute for real-time AI in the OR; ScoPilot AI module (FDA cleared March 18, 2025) autonomously positions the laparoscope to follow the instrument tip; the first FDA-cleared AI application running intraoperatively on any commercial surgical robotic platform; all deployed units updated December 2025 with 5G/Wi-Fi connectivity; Maestro Insights cloud analytics provides procedural metrics and facility-level coordination.

HeadquartersParis, FR
Founded2020
Corporate funding$87M
Team51-200
Deployments4
Open roles0
01

Company overview

Identity and operating footprint

Company typeRobot maker
Market segmentCorporate
StageSeries B
FoundersAnne Osdoit (CEO), Pr. Brice Gayet
Regions servedNorth America, Europe
Countries deployedFR, US
Service footprintHQ Paris, France; US office San Carlos CA; Maestro CE-marked and FDA-cleared; 2,300+ patients treated globally as of Dec 2025; all installed systems 5G/Wi-Fi connected
Last reviewed2026-07-05
MX

Robot models

Specifications remain vendor-claimed

Machinemedical

Maestro

  • Two flexible robotic arms that hold laparoscopic instruments and cameras during minimally invasive procedures

    vendor-stated functional description for OR assistance during soft tissue surgery

    Claim source
  • Supports 60+ types of minimally invasive surgery

    vendor-stated surgical indication breadth as of Dec 2025

    Claim source
DP

Deployment log

Announced and cited only

AnnouncedCustomerSiteCountryCountEvidence
2026-03-02CHU de RouenhospitalFRNot disclosedAnnouncement
2025-07-15Lee Health Gulf Coast Medical CenterhospitalUSNot disclosedAnnouncement
2025-01-01Surgeon's Point Surgery Centerambulatory surgery centerUSNot disclosedAnnouncement
2023-10-24Arnault Tzanck InstitutehospitalFRNot disclosedAnnouncement
CA

Funding history

Publicly announced rounds

Investors on recordSofinnova PartnersNVIDIA NVenturesGT Healthcare CapitalCathay HealthJohnson & Johnson Innovation – JJDC
TL

Company timeline

Milestones and announcements

2025-12-012,300+ patients treated globally; all Maestro units 5G/Wi-Fi connected; Maestro Insights cloud analytics launchedPRNewswire
2025-03-18ScoPilot AI autonomous camera-positioning module received FDA clearance: industry's first intraoperative AI feature on a commercial surgical robot, powered by NVIDIA HoloscanPRNewswire
2024-06-05Second FDA 510(k) clearance covering the commercial Maestro Robotic Surgery SystemPRNewswire
2023-09-19CE Mark granted for Maestro System; first commercial cases in France at Arnault Tzanck InstituteMoon Surgical
2023-05-01Raised $55.4M Series B co-led by Sofinnova Partners and NVIDIA NVentures; Fred Moll appointed Board ChairThe Robot Report
2022-12-06First FDA 510(k) clearance for Maestro SystemMoon Surgical
2022-05-01Raised $31.3M Series A led by GT Healthcare Capital with Sofinnova Partners, Cathay Health, and JJDCSofinnova Partners
SC

Source ledger

11 unique public sources